SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-20-015043
Filing Date
2020-08-03
Accepted
2020-08-03 16:49:37
Documents
3
Period of Report
2020-07-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp133650_8k.htm 8-K 20806
2 EXHIBIT 99.1 dp133650_ex9901.htm EX-99.1 9647
3 GRAPHIC image_001.jpg GRAPHIC 4863
  Complete submission text file 0000950103-20-015043.txt   38477
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 201069776
SIC: 2834 Pharmaceutical Preparations